CSPCY:OTCMKTS
CSPC Pharmaceuticals Group ADR
5,03 $
arrow_upward
+0,60%(+0,030) 1 d.
6. okt., 16:00:00 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: CSPCY…
Atvērt
4,91 $
Augsta
5,04 $
Zema
4,91 $
Tirgus kapitalizācija
115,17 mljrd.
Vid. apjoms
1,40 tūkst.
Apjoms
6,29 tūkst.
Augstākā 52 ned.
5,46 $
Zemākā 52 ned.
3,26 $
Beta
0,37
Apgrozībā esošās akcijas
2,88 mljrd.
Darbinieku skaits
19 tūkst.
Atvērt
4,91 $
Augsta
5,04 $
Zema
4,91 $
Tirgus kapitalizācija
115,17 mljrd.
Vid. apjoms
1,40 tūkst.
Apjoms
6,29 tūkst.
Augstākā 52 ned.
5,46 $
Zemākā 52 ned.
3,26 $
Beta
0,37
Apgrozībā esošās akcijas
2,88 mljrd.
Darbinieku skaits
19 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
AD HOC NEWS
·
pirms 10 stundām
CSPC Pharma stock gains 1.47 percent as eight trials head to ESMO 2026
TipRanks
·
pirms 1 dienas
CSPC to Showcase Breakthrough HER2 Oncology Data at ESMO 2026
Profils
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
Par “CSPC Pharmaceuticals Group ADR”
ĢenerāldirektorsZhang Cuilong
Darbinieki18,6 tūkst.
Dibināšanas datums1992
Galvenais birojs-
Sektors-
Tīmekļa vietnecspc.com.hk